Davenport & Co’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.8M | Sell |
685,637
-62,485
| -8% | -$1.9M | 0.11% | 151 |
|
2025
Q1 | $21.3M | Sell |
748,122
-21,349
| -3% | -$609K | 0.12% | 147 |
|
2024
Q4 | $25.4M | Sell |
769,471
-291
| -0% | -$9.62K | 0.14% | 136 |
|
2024
Q3 | $28.7M | Sell |
769,762
-1,138
| -0.1% | -$42.4K | 0.16% | 130 |
|
2024
Q2 | $25.7M | Sell |
770,900
-289
| -0% | -$9.63K | 0.16% | 132 |
|
2024
Q1 | $27.5M | Buy |
771,189
+83,403
| +12% | +$2.97M | 0.17% | 134 |
|
2023
Q4 | $22.7M | Sell |
687,786
-125
| -0% | -$4.13K | 0.15% | 130 |
|
2023
Q3 | $18.7M | Sell |
687,911
-3,242
| -0.5% | -$88.3K | 0.14% | 135 |
|
2023
Q2 | $21.8M | Buy |
691,153
+2,137
| +0.3% | +$67.4K | 0.16% | 129 |
|
2023
Q1 | $18.7M | Buy |
689,016
+77,616
| +13% | +$2.11M | 0.15% | 135 |
|
2022
Q4 | $18.5M | Buy |
+611,400
| New | +$18.5M | 0.15% | 134 |
|
2015
Q4 | – | Sell |
-42,587
| Closed | -$1.19M | – | 607 |
|
2015
Q3 | $1.19M | Buy |
+42,587
| New | +$1.19M | 0.02% | 248 |
|